1738 related articles for article (PubMed ID: 19168526)
21. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
Pimenta JM; Almeida R; Araújo JP; Azevedo A; Friões F; Rocha-Gonçalves F; Ferreira A; Bettencourt P
J Card Fail; 2007 May; 13(4):275-80. PubMed ID: 17517347
[TBL] [Abstract][Full Text] [Related]
22. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
[TBL] [Abstract][Full Text] [Related]
23. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
[TBL] [Abstract][Full Text] [Related]
24. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Rothenbacher D; Koenig W; Brenner H
Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
[TBL] [Abstract][Full Text] [Related]
25. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
[TBL] [Abstract][Full Text] [Related]
26. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
[TBL] [Abstract][Full Text] [Related]
27. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
[TBL] [Abstract][Full Text] [Related]
28. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction.
Drewniak W; Snopek G; Zarukiewicz M; Borys M; Dabrowski M
Kardiol Pol; 2008 Jul; 66(7):750-5; discussion 756-7. PubMed ID: 18690566
[TBL] [Abstract][Full Text] [Related]
30. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
[TBL] [Abstract][Full Text] [Related]
31. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
Palmer SC; Yandle TG; Frampton CM; Troughton RW; Nicholls MG; Richards AM
Eur Heart J; 2009 Jun; 30(12):1486-94. PubMed ID: 19389787
[TBL] [Abstract][Full Text] [Related]
32. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
[TBL] [Abstract][Full Text] [Related]
34. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
[TBL] [Abstract][Full Text] [Related]
36. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure.
Bayes-Genis A; Pascual-Figal D; Fabregat J; Domingo M; Planas F; Casas T; Ordoñez-Llanos J; Valdes M; Cinca J
Int J Cardiol; 2007 Sep; 120(3):338-43. PubMed ID: 17174423
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
Tang WH; Steinhubl SR; Van Lente F; Brennan D; McErlean E; Maroo A; Francis GS; Topol EJ
Am Heart J; 2007 Jan; 153(1):36-41. PubMed ID: 17174634
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
39. The value of NT-proBNP in early risk stratification of acute coronary syndromes.
Almeida R; Mariano L; Gavina C; Pinho T; Vasconcelos M; Ferreira A; Maciel MJ; Gonçalves FR
Rev Port Cardiol; 2006 Jan; 25(1):71-5. PubMed ID: 16623357
[TBL] [Abstract][Full Text] [Related]
40. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
